Next Article in Journal
The Effect of Integrating Service-Learning and Learning Portfolio Construction into the Curriculum of Gerontological Nursing
Next Article in Special Issue
Community Pharmacists’ Perceptions of Their Role in Provision of Anemia Management in Jazan Region, Saudi Arabia, and the Associated Barriers
Previous Article in Journal
The Progress of the New South Wales Aboriginal Oral Health Plan 2014–2020: A Scoping Review
 
 
Article
Peer-Review Record

Barriers to Medication Review Process Implementation—Cross-Sectional Study among Community Pharmacists in Jordan

Healthcare 2022, 10(4), 651; https://doi.org/10.3390/healthcare10040651
by Mohammad Abu Assab *, Hamza Alhamad, Inas Almazari, Bilyana Azzam and Hanadi Abu Assab
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Reviewer 3: Anonymous
Reviewer 4: Anonymous
Healthcare 2022, 10(4), 651; https://doi.org/10.3390/healthcare10040651
Submission received: 27 February 2022 / Revised: 24 March 2022 / Accepted: 25 March 2022 / Published: 31 March 2022
(This article belongs to the Special Issue Pharmacy Practice and Administration 2.0)

Round 1

Reviewer 1 Report

In the manuscript “Barriers Towards Medication Review Process Implementation-Cross-Sectional Study Among Community Pharmacists in Jordan”, the authors use survey to address the potential barriers confronting Medication Review Process (MPR) implementation among community pharmacists in Jordan. Their analysis shows that the rates of the barriers are remuneration (55.8%), regulations (52.3%), patient-related (48.8%), resources-related (44.6%), qualification-related (42.9%), and physicians-related (41.8%), respectively. So, the authors conclude that the top three rating barriers are strong facilitators for the community pharmacists to initiate the medication review service in Jordan.

The data and findings of this study are useful information for some countries or regions to enhance their medication review service.

Here are some suggestions that might help improve the manuscript:

1. The abbreviation “MRS” means medication review service?

(Page 2, Line 77;

Page 7, line 198, and line 234;

 Page8, Line 254;

Page 9, line 346 and 352.)

2. The section of the materials and methods: it might be easy to follow to represent the whole study process with a flow chart.

3. It could be better to summary the results with a circle graph (parts of whole graph).

4. Is there any suggestions about the data collection such as conducts for improvement for future research?

Author Response

Please see the attachment

Author Response File: Author Response.doc

Reviewer 2 Report

The authors described in details the barriers confronting Medication Review Process (MRP) implementation among community pharmacists in Jordan. Although the study was conducted in Jordan, the results might be of interest for other nations. The study identifies the advantages and obstacles with which the pharmacists may face worldwide. The authors emphasize also the need for the implementation of the aspect of MRP in the academic training, which is of great importance. The manuscript is well-written and interesting. My only comment is that in lines 47, 150, 151, 158 the abbreviation ‘MR’ was not explained and it seems as it stands for ‘medications review process’. The explanation appears as a table capture (line 164).

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Reviewer 3 Report

Comments for:  Barriers Towards Medication Review Process
Implementation-Cross-Sectional Study Among Community Pharmacists in Jordan

Lines 70-72 are missing references to support the theses.

The authors state that they used their own authorship, based on the scientific literature, a validated questionnaire. Please provide references on the basis of which the research questionnaire was created.

The authors report that 417 pharmacists answered the questionnaire, giving a response rate of 75.8%. What about missing data?

How many pharmacists were excluded from the study based on the inclusion and exclusion criteria?

In table no.3, I propose to additionally introduce the number N, similarly to table no.2.

I suggest supplementing the discussion with the strengths and limitation of the study.

The conclusions should be rewritten, they do not correspond with the obtained results. 

Author Response

Please see the attachment

Author Response File: Author Response.doc

Reviewer 4 Report

The implementation of medication review in community pharmacy is a worldwide challenge. The present manuscript is centred in Jordan, but the problems found by the authors do not differ from any other country.

 

I think that the main problem is that these problems exist since always, but little progress has been done to solve them.

 

Some thinks I would like to comment about the present work:

  • From what I can read in the manuscript I conclude that community pharmacists do not have access to the clinical record of the patient? Is that so? This is an important issue and one of these chronic problems.
  • The pharmacists that performed reviews, did they have any system for recording their interventions? As the authors indicate in the discussion, in order to demonstrate the value of MRP it is necessary to have data about the work done by the pharmacist.
  • Discussion: As one of the challenges found is the training of pharmacist, the authors indicate the need to include these issues in curriculum of studies of pharmacy. I can say that in many Universities we have these aspects included, but if after the graduation the pharmacist cannot apply them it his/hers everyday practice, with time these skills are forgotten.

Author Response

Please see the attachment

Author Response File: Author Response.doc

This manuscript is a resubmission of an earlier submission. The following is a list of the peer review reports and author responses from that submission.


Back to TopTop